Validations: AI/ML Model Validation in GxP Analytics

Data Drift from New Markets/Sites

Data Drift from New Markets/Sites Data Drift from New Markets/Sites In the rapidly advancing field of pharmaceuticals, the application of AI and machine learning (ML) models has become increasingly prevalent. However, navigating the complexities associated with data drift when using these models is essential to maintain compliance with Good Automated Manufacturing Practice (GxP) regulations. This step-by-step tutorial focuses on critical…

Continue Reading Data Drift from New Markets/Sites

Shadow Mode/Champion–Challenger: Safe Rollouts

Shadow Mode/Champion–Challenger: Safe Rollouts Shadow Mode/Champion–Challenger: Safe Rollouts in AI/ML Model Validation Understanding the Importance of AI/ML Model Validation in Pharmaceutical Labs The integration of artificial intelligence (AI) and machine learning (ML) models in pharmaceutical labs is rapidly evolving, facilitating enhancements in drug development, clinical trials, and overall laboratory analytics. However, ensuring the validity and compliance of these AI/ML models…

Continue Reading Shadow Mode/Champion–Challenger: Safe Rollouts

Change Control for Models: Verification vs Re-Validation

Change Control for Models: Verification vs Re-Validation The integration of Artificial Intelligence (AI) and Machine Learning (ML) models in Good Practice (GxP) regulated environments has introduced complexities in pharmacovigilance, clinical operations, and regulatory compliance. As pharma professionals navigate these complexities, it’s essential to establish a robust framework for model validation, focusing on the distinction between verification and re-validation, particularly in…

Continue Reading Change Control for Models: Verification vs Re-Validation

Triggers & Escalations: From Alerts to Action

Triggers & Escalations: From Alerts to Action Triggers & Escalations: From Alerts to Action The rapid integration of artificial intelligence (AI) and machine learning (ML) in Good Manufacturing Practice (GxP) analytics has initiated a need for rigorous validation processes. This tutorial outlines the comprehensive steps necessary for effective AI/ML model validation, focusing on the identification of triggers and escaling procedures…

Continue Reading Triggers & Escalations: From Alerts to Action

A/B Tests and Backtests in Regulated Analytics

A/B Tests and Backtests in Regulated Analytics A/B Tests and Backtests in Regulated Analytics In the realm of AI and machine learning (ML) used in Good Automated Manufacturing Practice (GxP) analytics, A/B testing and backtesting represent crucial methodologies for validation and monitoring of models implemented in various laboratories. With the increasing incorporation of advanced technologies in regulated environments, understanding these…

Continue Reading A/B Tests and Backtests in Regulated Analytics

Monitoring Bias Post-Deployment

Monitoring Bias Post-Deployment Monitoring Bias Post-Deployment in AI/ML GxP Analytics Introduction to AI/ML Model Validation in GxP Analytics As the integration of AI/ML technologies into pharmaceutical operations grows, monitoring and validating these systems in compliance with Good Automated Manufacturing Practice (GxP) standards becomes crucial. AI/ML model validation entails rigorous processes to ensure that algorithms operate as intended, maintain data integrity,…

Continue Reading Monitoring Bias Post-Deployment

KPI Sets for Model Validation Programs

KPI Sets for Model Validation Programs KPI Sets for Model Validation Programs Understanding the Importance of Model Validation in Pharmaceutical Development Model validation in the pharmaceutical industry, particularly with the advent of artificial intelligence and machine learning (AI/ML), has become a critical aspect of ensuring compliance within Good Automated Manufacturing Practice (GxP) guidelines. It is imperative to establish clear Key…

Continue Reading KPI Sets for Model Validation Programs

Peer Review Checklists for Model Evidence

Peer Review Checklists for Model Evidence Peer Review Checklists for Model Evidence in AI/ML Model Validation Introduction to AI/ML Model Validation in GxP Analytics In recent years, the incorporation of artificial intelligence (AI) and machine learning (ML) in Good Practice (GxP) analytics has brought a wave of innovations in pharmaceutical development and clinical research. However, the validation of these AIs…

Continue Reading Peer Review Checklists for Model Evidence

Drift Taxonomy: Data, Concept, Label, and Pipeline

Drift Taxonomy: Data, Concept, Label, and Pipeline Understanding AI/ML Model Validation in GxP Analytics The integration of AI and machine learning (ML) technologies in pharmaceutical laboratories is rapidly evolving. However, this progress necessitates rigorous validation practices to ensure compliance with Good Practice (GxP) standards. AI/ML model validation within GxP analytics involves a comprehensive assessment of model performance, reliability, and adherence…

Continue Reading Drift Taxonomy: Data, Concept, Label, and Pipeline

Linking Model Specs to URS and Risk

Linking Model Specs to URS and Risk Linking Model Specs to URS and Risk Introduction to AI/ML Model Validation in GxP Analytics In the pharmaceutical industry, the application of artificial intelligence (AI) and machine learning (ML) is becoming increasingly integral to regulatory compliance, drug development, and clinical operations. However, ensuring proper validation of these models is essential for maintaining quality…

Continue Reading Linking Model Specs to URS and Risk